Teva Pharmaceutical Industries Ltd (TEVA) — Free Cash Flow Generation Index
Teva Pharmaceutical Industries Ltd (TEVA) has a Free Cash Flow Generation Index of 0.86x as of June 2026. Free cash flow of ILA620.33 Million represents 1% of operating cash flow (ILA721.91 Million). Explore TEVA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Ltd Free Cash Flow Generation Index (1991–2025)
Historical FCF Generation Index trend for Teva Pharmaceutical Industries Ltd across 34 annual periods. For the full cash flow conversion analysis, see Teva Pharmaceutical Industries Ltd cash flow conversion.
Annual Free Cash Flow Generation for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year Free Cash Flow Generation Index for Teva Pharmaceutical Industries Ltd. Check Teva Pharmaceutical Industries Ltd (TEVA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | ILA2.56 Billion | ILA3.10 Billion | ILA542.32 Million | ▲ +37.4% |
| 2024 | 0.60x | ILA749.00 Million | ILA1.25 Billion | ILA498.00 Million | ▼ -2.4% |
| 2023 | 0.62x | ILA842.00 Million | ILA1.37 Billion | ILA526.00 Million | ▼ -6.1% |
| 2022 | 0.66x | ILA1.04 Billion | ILA1.59 Billion | ILA548.00 Million | ▲ +121.6% |
| 2021 | 0.30x | ILA236.00 Million | ILA798.00 Million | ILA562.00 Million | ▼ -43.6% |
| 2020 | 0.52x | ILA638.00 Million | ILA1.22 Billion | ILA578.00 Million | ▼ -32.6% |
| 2019 | 0.78x | ILA419.00 Million | ILA538.00 Million | ILA119.00 Million | ▲ +6.1% |
| 2018 | 0.73x | ILA1.79 Billion | ILA2.45 Billion | ILA651.00 Million | ▼ -2.3% |
| 2017 | 0.75x | ILA2.63 Billion | ILA3.51 Billion | ILA874.00 Million | ▼ -9.3% |
| 2016 | 0.83x | ILA4.32 Billion | ILA5.22 Billion | ILA901.00 Million | ▼ -3.9% |
| 2015 | 0.86x | ILA4.77 Billion | ILA5.54 Billion | ILA772.00 Million | ▲ +5.1% |
| 2014 | 0.82x | ILA4.20 Billion | ILA5.13 Billion | ILA929.00 Million | ▲ +20.1% |
| 2013 | 0.68x | ILA2.21 Billion | ILA3.24 Billion | ILA1.03 Billion | ▼ -10.2% |
| 2012 | 0.76x | ILA3.47 Billion | ILA4.57 Billion | ILA1.10 Billion | ▲ +1.8% |
| 2011 | 0.75x | ILA3.08 Billion | ILA4.13 Billion | ILA1.05 Billion | ▼ -10.0% |
| 2010 | 0.83x | ILA3.43 Billion | ILA4.14 Billion | ILA710.00 Million | ▲ +5.3% |
| 2009 | 0.79x | ILA2.65 Billion | ILA3.37 Billion | ILA719.00 Million | ▼ -0.3% |
| 2008 | 0.79x | ILA2.55 Billion | ILA3.23 Billion | ILA681.00 Million | ▲ +12.6% |
| 2007 | 0.70x | ILA1.27 Billion | ILA1.81 Billion | ILA542.00 Million | ▼ -13.5% |
| 2006 | 0.81x | ILA1.67 Billion | ILA2.06 Billion | ILA390.00 Million | ▲ +4.8% |
| 2005 | 0.77x | ILA1.06 Billion | ILA1.37 Billion | ILA310.10 Million | ▲ +3.0% |
| 2004 | 0.75x | ILA937.80 Million | ILA1.25 Billion | ILA311.00 Million | ▲ +12.3% |
| 2003 | 0.67x | ILA419.10 Million | ILA626.60 Million | ILA207.50 Million | ▲ +22.4% |
| 2002 | 0.55x | ILA193.30 Million | ILA353.70 Million | ILA160.40 Million | ▲ +7.3% |
| 2001 | 0.51x | ILA139.08 Million | ILA273.15 Million | ILA134.07 Million | ▲ +10.7% |
| 2000 | 0.46x | ILA76.21 Million | ILA165.63 Million | ILA89.42 Million | ▼ -18.3% |
| 1999 | 0.56x | ILA86.53 Million | ILA153.61 Million | ILA67.07 Million | ▲ +160.5% |
| 1998 | -0.93x | ILA-65.40 Million | ILA70.20 Million | ILA135.60 Million | ▼ -238.5% |
| 1997 | 0.67x | ILA130.20 Million | ILA193.60 Million | ILA63.40 Million | ▲ +1084.5% |
| 1995 | -0.07x | ILA-7.20 Million | ILA105.40 Million | ILA112.60 Million | ▲ +93.7% |
| 1994 | -1.08x | ILA-41.30 Million | ILA38.20 Million | ILA79.50 Million | ▼ -436.3% |
| 1993 | -0.20x | ILA-7.60 Million | ILA37.70 Million | ILA45.30 Million | ▼ -731.7% |
| 1992 | 0.03x | ILA900.00K | ILA28.20 Million | ILA27.30 Million | ▲ +102.2% |
| 1991 | -1.45x | ILA-13.20 Million | ILA9.10 Million | ILA22.30 Million | — |